Naftin is a Topical Gel in the Human Prescription Drug category. It is labeled and distributed by Sebela Pharmaceuticals Inc.. The primary component is Naftifine Hydrochloride.
Product ID | 54766-770_7d8a5d94-b15d-89f8-e053-2a91aa0a104b |
NDC | 54766-770 |
Product Type | Human Prescription Drug |
Proprietary Name | Naftin |
Generic Name | Naftifine Hydrochloride |
Dosage Form | Gel |
Route of Administration | TOPICAL |
Marketing Start Date | 2018-01-22 |
Marketing Category | NDA / NDA |
Application Number | NDA019356 |
Labeler Name | Sebela Pharmaceuticals Inc. |
Substance Name | NAFTIFINE HYDROCHLORIDE |
Active Ingredient Strength | 10 mg/g |
Pharm Classes | Allylamine [CS],Allylamine Antifungal [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2018-01-22 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA019356 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | GM |
Marketing Start Date | 2018-01-22 |
Marketing Category | NDA |
Application Number | NDA019356 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | GM |
Marketing Start Date | 2018-01-22 |
Marketing Category | NDA |
Application Number | NDA019356 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | GM |
Marketing Start Date | 2018-01-22 |
Ingredient | Strength |
---|---|
NAFTIFINE HYDROCHLORIDE | 10 mg/g |
SPL SET ID: | 6371fceb-b98e-86a5-e053-2a91aa0a3d9e |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
0259-4126 | Naftin | NAFTIFINE HYDROCHLORIDE |
54766-102 | Naftin | Naftifine Hydrochloride |
54766-770 | Naftin | NAFTIFINE HYDROCHLORIDE |
54766-772 | Naftin | Naftifine Hydrochloride |
0115-1510 | NAFTIFINE HYDROCHLORIDE | NAFTIFINE HYDROCHLORIDE |
0115-1512 | NAFTIFINE HYDROCHLORIDE | NAFTIFINE HYDROCHLORIDE |
40085-201 | Naftifine Hydrochloride | NAFTIFINE HYDROCHLORIDE |
40085-203 | Naftifine Hydrochloride | NAFTIFINE HYDROCHLORIDE |
51672-1362 | Naftifine Hydrochloride | Naftifine Hydrochloride |
51672-1368 | Naftifine Hydrochloride | Naftifine Hydrochloride |
51672-1376 | Naftifine Hydrochloride | Naftifine Hydrochloride |
70700-161 | Naftifine hydrochloride | Naftifine hydrochloride |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
NAFTIN 73706755 not registered Dead/Abandoned |
THAMES PHARMACAL CO., INC. 1988-01-21 |
NAFTIN 73589735 1412990 Live/Registered |
ALLERGAN PHARMACEUTICALS, INC. 1986-03-24 |